Nordea Investment Management AB decreased its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 14.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,058,564 shares of the semiconductor company’s stock after selling 181,885 shares during the period. Nordea Investment Management AB owned 0.68% of Synopsys worth $544,928,000 at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in SNPS. Hemington Wealth Management increased its position in shares of Synopsys by 10.1% during the 2nd quarter. Hemington Wealth Management now owns 197 shares of the semiconductor company’s stock valued at $100,000 after purchasing an additional 18 shares during the period. Concord Asset Management LLC VA grew its holdings in shares of Synopsys by 0.8% in the 2nd quarter. Concord Asset Management LLC VA now owns 2,379 shares of the semiconductor company’s stock worth $1,220,000 after acquiring an additional 18 shares during the last quarter. MCF Advisors LLC grew its holdings in shares of Synopsys by 16.2% in the 2nd quarter. MCF Advisors LLC now owns 136 shares of the semiconductor company’s stock worth $70,000 after acquiring an additional 19 shares during the last quarter. Capital Advisors Ltd. LLC grew its holdings in shares of Synopsys by 14.5% in the 2nd quarter. Capital Advisors Ltd. LLC now owns 158 shares of the semiconductor company’s stock worth $81,000 after acquiring an additional 20 shares during the last quarter. Finally, Trust Point Inc. grew its holdings in shares of Synopsys by 4.4% in the 2nd quarter. Trust Point Inc. now owns 494 shares of the semiconductor company’s stock worth $253,000 after acquiring an additional 21 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.
Analysts Set New Price Targets
SNPS has been the topic of a number of recent research reports. KeyCorp decreased their target price on Synopsys from $660.00 to $590.00 and set an “overweight” rating on the stock in a report on Wednesday, September 10th. Needham & Company LLC decreased their target price on Synopsys from $660.00 to $550.00 and set a “buy” rating on the stock in a report on Wednesday, September 10th. The Goldman Sachs Group decreased their target price on Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a report on Wednesday, September 10th. Robert W. Baird restated a “neutral” rating and issued a $535.00 target price (down from $670.00) on shares of Synopsys in a report on Wednesday, September 10th. Finally, JPMorgan Chase & Co. decreased their target price on Synopsys from $685.00 to $600.00 and set an “overweight” rating on the stock in a report on Wednesday, September 10th. Ten equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat, Synopsys currently has a consensus rating of “Hold” and a consensus price target of $569.67.
Insider Transactions at Synopsys
In related news, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the completion of the sale, the chief accounting officer owned 20,520 shares of the company’s stock, valued at approximately $10,278,468. This trade represents a 32.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert G. Painter acquired 350 shares of Synopsys stock in a transaction that occurred on Thursday, September 11th. The shares were purchased at an average cost of $425.44 per share, with a total value of $148,904.00. Following the transaction, the director owned 2,291 shares of the company’s stock, valued at approximately $974,683.04. The trade was a 18.03% increase in their position. The disclosure for this purchase can be found here. Insiders sold a total of 30,894 shares of company stock worth $16,760,783 in the last ninety days. Company insiders own 0.62% of the company’s stock.
Synopsys Stock Performance
Shares of SNPS stock opened at $440.20 on Friday. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $81.77 billion, a price-to-earnings ratio of 34.55, a P/E/G ratio of 4.80 and a beta of 1.10. The stock’s fifty day simple moving average is $529.15 and its 200-day simple moving average is $510.15.
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The business had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.77 billion. During the same quarter in the prior year, the firm posted $3.43 EPS. The business’s quarterly revenue was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, sell-side analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Salesforce’s Long-Awaited Inflection is Here: Rally On!
- How to Profit From Growth Investing
- Rocket Lab USA Receives Wall Street Validation: Time to Buy?
- How Technical Indicators Can Help You Find Oversold Stocks
- Archer Buys Rival’s Patent Treasure Trove in Strategic Move
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.